The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes
Open accessAbstract
Adiponectin exerts renoprotective effects against diabetic nephropathy (DN) by activating the AMP-activated protein kinase (AMPK)/peroxisome proliferative-activated receptor– α (PPAR α ) pathway through adiponectin receptors (AdipoRs). AdipoRon is an orally active synthetic adiponectin receptor agonist. We investigated the expression of AdipoRs and the associated intracellular pathways in 27 patients with type 2 diabetes and examined the effects of AdipoRon on DN development in male C57BLKS/J db/db mice, glomerular endothelial cells (GECs), and podocytes. The extent of glomerulosclerosis and tubulointerstitial fibrosis correlated with renal function deterioration in human kidneys. Expression of AdipoR1, AdipoR2, and Ca 2+ /calmodulin-dependent protein kinase kinase– β (CaMKK β ) and numbers of phosphorylated liver kinase B1 (LKB1)– and AMPK-positive cells significantly decreased in the glomeruli of early stage human DN. AdipoRon treatment restored diabetes-induced renal alterations in db/db mice. AdipoRon exerted renoprotective effects by directly activating intrarenal AdipoR1 and AdipoR2, which increased CaMKK β , phosphorylated Ser 431 LKB1, phosphorylated Thr 172 AMPK, and PPAR α expression independently of the systemic effects of adiponectin. AdipoRon-induced improvement in diabetes-induced oxidative stress and inhibition of apoptosis in the kidneys ameliorated relevant intracellular pathways associated with lipid accumulation and endothelial dysfunction. In high-glucose–treated human GECs and murine podocytes, AdipoRon increased intracellular Ca 2+ levels that activated a CaMKK β /phosphorylated Ser 431 LKB1/phosphorylated Thr 172 AMPK/PPAR α pathway and downstream signaling, thus decreasing high-glucose–induced oxidative stress and apoptosis and improving endothelial dysfunction. AdipoRon further produced cardioprotective effects through the same pathway demonstrated in the kidney. Our results show that AdipoRon ameliorates GEC and podocyte injury by activating the intracellular Ca 2+ /LKB1-AMPK/PPAR α pathway, suggesting its efficacy for treating type 2 diabetes–associated DN.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AdipoRon has first been proposed for the treatment of type 2 diabetes and other obesity-related disorders in mice [32,106,107,108,137,138].”
From Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together? (2020) · cites this paper as [32]
Citations
Cites
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Woods, A., Dickerson, K., Heath, R. B., Hong, S. P., Momcilovic, M., Johnstone, S. R., Carlson, M., & Carling, D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.005 · Cited by 1,418
Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T., et al. (2007) · Nature Medicine · doi:10.1038/nm1557 · Cited by 1,396
Adiponectin and AdipoR1 Regulate PGC-1α and Mitochondria by Ca2+ and AMPK/SIRT1
Iwabu, M., Yamauchi, T., Okada-Iwabu, M., Sato, K., Nakagawa, T., Funata, M., Yamaguchi, M., Namiki, S., Nakayama, R., Tabata, M., et al. (2010) · Nature · doi:10.1038/nature08991 · Cited by 971
Mundel, P. H., Reiser, J., Zúñiga, A., Pavenstädt, H., Davidson, G. R., Kriz, W., & Zeller, R. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3739 · Cited by 876
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
Okada-Iwabu, M., Yamauchi, T., Iwabu, M., Honma, T., Hamagami, K.-I., Matsuda, K., Yamaguchi, M., Tanabe, H., Kimura-Someya, T., Shirouzu, M., et al. (2013) · Nature · doi:10.1038/nature12656 · Cited by 757
Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade
Sanders, M. J., Grondin, P., Hegarty, B. D., Snowden, M. A., & Carling, D. (2007) · Biochemical Journal · doi:10.1042/bj20061520 · Cited by 677
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 228
Lin, F., Liu, Y., Rudeski-Rohr, T., Dahir, N. S., Calder, A. N., & Gilbertson, T. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065801 · Cited by 16
Fauzi, A., Thoe, E. S., Quan, T. Y., & Yin, A. C. Y. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108629 · Cited by 17
Wang, Y., Liu, Y., Fang, J., Xing, X., Wang, H., Shi, X., Liu, X., Niu, T., & Liu, K. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04783-3 · Cited by 16
Rajput, S., Kulkarni, C., Sharma, S., Tomar, M. S., Khatoon, S., Gupta, A., Sanyal, S., Shrivastava, A., Ghosh, J. K., & Chattopadhyay, N. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01509-x · Cited by 15
Hu, X., Ouyang, Q., Wang, L., Li, T., Xie, X., & Liu, J. L. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy152 · Cited by 15
Wang, Z., Tang, J., Li, Y., Wang, Y., Guo, Y., Tu, Q., Chen, J., & Wang, C. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111757 · Cited by 15
Role of adiponectin in osteoarthritis
Feng, X., Xiao, J., & Bai, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.992764 · Cited by 15
Yue, H., Zhang, Q., Chang, S., Zhao, X., Wang, M., & Li, W. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02028-w · Cited by 14
Role of peroxisomes in the pathogenesis and therapy of renal fibrosis
Zhang, D., Zhang, Y.-H., Liu, B., Yang, H., Li, G., Zhou, H., & Wang, Y. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156173 · Cited by 14
Kim, T., Oum, S.-J., Lim, J. H., Kim, Y., Kim, E. N., Jin, Y., Hong, Y. A., Chae, S. Y., Choi, B. S., Kim, H. W., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02326-5 · Cited by 13
The mysterious association between adiponectin and endometriosis
Zhao, Y.-Q., Ren, Y., Li, B., Wei, C., & Yu, B. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1396616 · Cited by 13
Hu, J., Zhu, Z., Zhang, Z., Hu, H., & Yang, Q. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122722 · Cited by 13
Uchida, T., Ueta, T., Honjo, M., & Aihara, M. (2019) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2018.0152 · Cited by 13
Reduced serum CTRP12 levels in type 2 diabetes are associated with renal dysfunction
Du, J., Xu, J., Wang, X., Liu, Y., Zhao, X., & Zhang, H. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02591-y · Cited by 13
Xiong, S., Han, Y., Gao, P., Zhao, H., Jiang, N., & Sun, L. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6104375 · Cited by 13
Rashtiani, S., Goudarzi, I., Jafari, A., & Rohampour, K. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135721 · Cited by 13
Bagherifard, A., Hemmatyar, A., Khosravi, K., Rouzbahani, A., Mokhtari, K., Yahyazedeh, H., & Tanzadehpanah, H. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01907-1 · Cited by 16
Adiponectin agonist treatment in diabetic pregnant rats
Gázquez, A., Rodríguez, F., Sánchez-Campillo, M., Gascón, L. M., Arnao, M. B., Saura-Garre, P., Albaladejo-Otón, M. D., & Larqué, E. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0617 · Cited by 12
Laurindo, L. F., Laurindo, L. F., Rodrigues, V. D., Catharin, V. M. C. S., Simili, O. A. G., Barboza, G. D. O., Catharin, V. C. S., Sloan, K. P., & Barbalho, S. M. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03362-7 · Cited by 12
Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice
Xiao, W., & Zhang, L. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000488 · Cited by 12
Sun, R., Han, M., Liu, Y., Su, Y., Shi, Q., Huang, L., Kong, L., Li, W., & Li, W. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13136 · Cited by 11
Antidiabetic features of AdipoAI, a novel AdipoR agonist
Ahuja, A., Zboinski, E., das, S., Zhu, X., Ma, Q., Xie, Y., Tu, Q., & Chen, J. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.3910 · Cited by 11
Zha, D., Yao, T., Bao, L., Gao, P. H., & Wu, X. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.01.044 · Cited by 11
Bayram, B., Owen, A. R., Dudakovic, A., Dagneaux, L., Turner, T. W., Bettencourt, J. W., Limberg, A. K., Tibbo, M. E., Morrey, M. E., Sánchez‐Sotelo, J., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113690 · Cited by 11
AdipoRon ameliorates chronic ethanol induced cardiac necroptosis by reducing ceramide mediated mtROS
Qian, Y., Qi, Y., Lin, J., Zhang, T., Mo, L., Xue, Q., Zheng, N., Niu, Y., Dong, X., Shi, Y., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.01.018 · Cited by 10
Guo, H., Ou, H., Yu, J., Rosa, J. M., Formolo, D. A., Cheng, T., Yau, S., & Tsang, H. W. H. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-00943 · Cited by 11
From diabetes to renal aging: the therapeutic potential of adiponectin
Karamian, M., Moossavi, M., & Hemmati, M. (2021) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-021-00790-4 · Cited by 9
Nam, H., Lim, J., Kim, T., Kim, E. S., Oum, S.-J., Bae, S. H., & Park, C. (2023) · Antioxidants · doi:10.3390/antiox12122040 · Cited by 9
Adiponectin as a therapeutic target for diabetic foot ulcer
Abdalla, M. M. I., Mohanraj, J., & Somanath, S. D. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i6.758 · Cited by 10
Matsuta, K., Kamiyama, K., Imamoto, T., Takeda, I., Masunaga, S., Kobayashi, M., Takahashi, N., Kasuno, K., Hara, M., Iwano, M., et al. (2024) · Cells · doi:10.3390/cells13171446 · Cited by 9
Adiponectin is not associated with renal function decline in community-dwelling elderly adults
Kobayashi, H. H., Otsuka, H., Yanai, M., Haketa, A., Hara, M., Hishiki, M., Abe, M., & Soma, M. (2018) · Medicine · doi:10.1097/md.0000000000010847 · Cited by 9
Tarkhnishvili, A., Koentges, C., Pfeil, K., Gollmer, J., Byrne, N. J., Vosko, I., Lueg, J. C., Vogelbacher, L., Birkle, S., Tang, S., et al. (2022) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2022.11.2.161 · Cited by 9
Silva, I. M. S., Steckelings, U. M., & Assersen, K. B. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00269.2022 · Cited by 7
AdipoRs- a potential therapeutic target for fibrotic disorders
Ma, L., Li, X., Bai, Z., Lin, X., & Lin, K. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1559823 · Cited by 9
Shi, J., Wang, Q., Li, C., Yang, M., Hussain, M., Zhang, J., Feng, F., & Zhong, H. (2023) · Molecules · doi:10.3390/molecules28020722 · Cited by 8
ADIPOR1 regulates genes involved in milk fat metabolism in goat mammary epithelial cells
Zhao, W., Adjei, M., Wang, H., Yangliu, Y., Zhu, J., & Wu, H. (2021) · Research in Veterinary Science · doi:10.1016/j.rvsc.2021.04.001 · Cited by 7
Zhang, B., Bu, C., Wang, Q., Chen, Q., Shi, D., Qiu, H., Wang, Z., Liu, J., Wang, Z., Zhang, Q., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107493 · Cited by 7
Adiponectin receptor agonist AdipoRon alleviates memory impairment in the hippocampus of septic mice
Bai, G., Ling, J., Lu, J. F., Fang, M., & Yu, S. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115174 · Cited by 7
Adipose-Renal Axis in Diabetic Nephropathy
Yang, M., Song, P., Zhao, L., & Wang, X. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220806115518 · Cited by 7
Pabalan, N., Tiongco, R. E., Pandac, J. K., Paragas, N. A., Lasta, S. L., Gallego, N., Jarjanazi, H., & Pineda-Cortel, M. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208905 · Cited by 7
Challenging Sarcopenia: Exploring AdipoRon in Aging Skeletal Muscle as a Healthspan-Extending Shield
Selvais, C. M., de Carrizosa, M. A. D., Versele, R., Dubuisson, N., Noël, L., Brichard, S. M., & Abou‐Samra, M. (2024) · Antioxidants · doi:10.3390/antiox13091073 · Cited by 7
Zhou, J., Wang, S., Lou, J., Pan, B., Zhao, M., Li, Q., Zhou, J., Du, Y., Ding, S., Yu, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65978-4 · Cited by 8
Liu, Y., Xu, Y., Ji, H., Gao, F., Ge, R., Zhou, D., Fu, H., Liu, X., & Ma, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011277 · Cited by 6
Association of diabetic nephropathy with lipid metabolism: a Mendelian randomization study
Xie, P., Xie, W., Wang, Z., Guo, Z., Tang, R., Yang, H., Yu, W., Zhou, L., Huang, Y., Zhao, L., et al. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01641-8 · Cited by 6
AdipoRon Engages Microglia to Antinociception through the AdipoR1/AMPK Pathway in SNI Mice
Fang, Q., Li, J., Wang, Y., Liu, X., Shi, Y., Chen, J., Zhan, H., Zeng, Y., & Wu, W. (2023) · Mediators of Inflammation · doi:10.1155/2023/7661791 · Cited by 7
Wang, X., Wang, T., Yu, P., Li, Y., & Lv, X. (2024) · Frontiers in Plant Science · doi:10.3389/fpls.2024.1343154 · Cited by 6
Qin, J., Chen, Z., Ye, M., Liang, L., & Ding, X. (2025) · Autoimmunity · doi:10.1080/08916934.2025.2576881 · Cited by 5
Gong, H., Liu, Y., Liu, X., Niu, B., Kong, J., Wang, B., Lin, X., Lin, L., & Bi, Y. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05383-6 · Cited by 5
Nie, G., Liu, M., Yang, L., Li, C., Qu, C., Wang, J., Mei, J., Wang, Y., Han, L., Zhang, X., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1733950 · Cited by 5
Li, J., Li, J., Ullah, A., Shi, X., Zhang, X., Cui, Z., Lyu, Q., & Kou, G. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c09386 · Cited by 5
Sun, Y., Li, B., Song, B., Xia, Y., Ye, Z., Lin, F., Zhou, X., Li, W., Rao, T., & Fan, C. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-09991-9 · Cited by 5
Hyperlipidemic plasma molecules bind and inhibit adiponectin activity
Zhang, Y., Fan, S., Wang, W., Lau, W. B., Dai, J., Zhang, H., Wang, X., Liu, X., & Li, R. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13746 · Cited by 5
Wang, G., Deng, J., & Zhou, H. (2024) · PubMed Central · doi:10.22038/ijbms.2023.73385.15942 · Cited by 5
Salmons, H. I., Carstens, M. F., Limberg, A. K., Bettencourt, J. W., Payne, A. N., Karczewski, D. C., Ryan, Z., Morrey, M. E., Sánchez‐Sotelo, J., Berry, D. J., et al. (2024) · Journal of Orthopaedic Research® · doi:10.1002/jor.25853 · Cited by 5
Thomas, H. Y., & Versypt, A. N. F. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1481768 · Cited by 6
Fenofibrate Exerts Protective Effects in Diabetic Retinopathy
Chen, S., Wang, X., Sun, D., Zhang, S., Liu, P., Xu, X., Wei, F., & Liu, Q. (2025) · Current Eye Research · doi:10.1080/02713683.2025.2516802 · Cited by 5
Ghaffari, T., Moradi, N., Chamani, E., Ebadi, Z., Fadaei, R., Alizadeh‐Fanalou, S., Yarahmadi, S., & Fallah, S. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220401143249 · Cited by 5
Feng, J., Ma, X., Liu, Y., Shi, X., Jin, L., Le, Y., Zhang, Q., & Wang, C. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.4c07051 · Cited by 4
Analysis of high glucose injury using human induced pluripotent stem cell-derived kidney organoids
Qian, Z., Yang, D., Li, Y., Dong, R., Da, J., Chen, Y., & Zha, Y. (2026) · BMC Nephrology · doi:10.1186/s12882-025-04566-6 · Cited by 4
Pathak, M. P., Das, A., Patowary, P., & Chattopadhyay, P. (2020) · Biochimie · doi:10.1016/j.biochi.2020.05.008 · Cited by 4
Bai, Y., Chen, Z., Wen, Z., Long, X., Mo, Z., & Xu, J. (2021) · Nephrology · doi:10.1111/nep.13836 · Cited by 4
AdipoRon accelerates bone repair of calvarial defect in diet-induced obesity mice
Wu, X., Zhu, D., Shi, L., Tu, Q., Yu, Y., & Chen, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13975 · Cited by 4
DsbA-L: A Promising Therapeutic Target for Metabolic Diseases
Yang, M., Luo, S., Yang, J., Chen, W., He, L., Liu, D., Wang, X., Xiao, L., & Sun, L. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673252630231018044159 · Cited by 4
Nong, H., Song, X., Li, Y., Xu, Y., Wang, F., Wang, Y., Zhang, J., Chen, C., & Li, J. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137577 · Cited by 5
Effects of metformin on knee joint capsule fibrosis in a diabetic mouse model
Naito, T., Yamanaka, Y., Tokuda, K., Sato, N., Tajima, T., Tsukamoto, M., Suzuki, H., Kawasaki, M., Nakamura, E., & Sakai, A. (2024) · Bone and Joint Research · doi:10.1302/2046-3758.137.bjr-2023-0384.r1 · Cited by 4
Abou‐Samra, M., Dubuisson, N., Marino, A., Selvais, C. M., Versele, R., de Carrizosa, M. A. D., Noël, L., Beauloye, C., Brichard, S. M., & Horman, S. (2024) · Antioxidants · doi:10.3390/antiox13121551 · Cited by 4
Lindfors, S., Schmotz, C., Lewandowski, D., Hau, A., Saikko, L., Lehtonen, E., Majaniemi, V., Karhe, M., Naams, J.-B., Nísen, H., et al. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000611 · Cited by 4
Association of Serum Unsaturated Fatty Acid Patterns with the Risk of Diabetic Nephropathy
Shuang, X., Li, X., Hou, Q., Xu, N., Lu, Q., Wang, S., & Dai, C. (2024) · Kidney Diseases · doi:10.1159/000536532 · Cited by 3
Li, G., Huang, D., Kidd, J. M., Zou, Y., Wu, X., Zhang, Y., Gehr, T. W. B., Li, N., & Li, P. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103757 · Cited by 4
Zhang, S., Wen, Z., Xu, X., Zhou, Y., Chen, Y., Zhang, Y., Kan, Z., Wang, J., Wu, B., Chen, C., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.157836 · Cited by 3
Wang, Y., & Zhang, L. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1783519 · Cited by 3
Lin, C., Sun, G., & Li, Y. (2024) · RSC Medicinal Chemistry · doi:10.1039/d3md00727h · Cited by 3
FGF21 ameliorates diabetic nephropathy through CDK1-dependently regulating the cell cycle
Zhang, Y., Wang, F., Zhang, C., Yao, F., Zhang, B., Zhang, Y., & Sun, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1500458 · Cited by 3
The Pathological Mechanisms of Obesity-Related Glomerulopathy: A review article
Kasim, A. A., & Ataimish, A. H. (2021) · Iraqi Journal of Pharmaceutical Sciences · doi:10.31351/vol30iss1pp22-28 · Cited by 3
Clinical characteristics and treatment compounds of obesity-related kidney injury
Mao, T., Huang, H.-Q., & Zhang, C.-H. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i6.1091 · Cited by 3
Tong, Y., Li, X., Zhu, Y., Liao, X., & Zhang, L. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118713 · Cited by 2
Cheng, Y., Lv, S., & Liu, R. (2026) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-025-05505-9 · Cited by 2
Chen, S., Wang, Y. Q., Gao, J., Lin, J., Liu, L., Zhu, S., Liu, L., Xu, C., Liu, X., Zhu, M., et al. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.114886 · Cited by 2
The adiponectin-depression nexus: a brief review of mechanisms and therapeutic opportunities
Li, W., Murtaza, I., & Ali, T. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-025-01757-w · Cited by 2
Zheng, Z., Li, Y., & Pan, Y. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-03117-8 · Cited by 4
Lin, Y., Song, G., Chen, Y., Liang, C., Ni, Z., Gong, L., & Yan, Y. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00321.2025 · Cited by 3
Fumeron, F., Boustany, R. E., Bastard, J., Fellahi, S., Balkau, B., Marre, M., Venteclef, N., Velho, G., & Roussel, R. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa228 · Cited by 2
Renal lipid deposition and diabetic nephropathy
Yang, M., Liu, Y., Luo, S., Xiao, Y., Zhao, C., & Sun, L. (2023) · Diabetic Nephropathy · doi:10.2478/dine-2023-0001 · Cited by 2
Wan, Y., Zhang, L., Wang, L., Zhang, Y., & Gao, F. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110371 · Cited by 2
Adiponectin receptor agonist adipoRon alleviates imiquimod-induced murine psoriasis
Sun, G., Zhao, H.-Q., Huang, Y.-Y., Guo, Z., Zhang, L., Zhu, H., Wang, X., Ye, H.-N., & Chen, C. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114568 · Cited by 2
Endocrinology: past, present and future
Verbovoy, A. F., Dolgikh, Y. A., Verbovaya, N. I., & Galkin, R. A. (2022) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2022-11-3-37-46 · Cited by 2
Zhuang, N.-N., & You, H. (2025) · Healthcare and Rehabilitation · doi:10.1016/j.hcr.2024.100005 · Cited by 1
The relationship between carotenoids and diabetic nephropathy: insights from NHANES
Wang, L., Feng, T., Tan, Y., Zhang, J., Zhang, T., Huo, J., Song, X., Lin, X., Li, M., Liang, W., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1584692 · Cited by 1
Yang, X., Wang, Q., Nie, H., Wang, M., Wang, Y., Li, S., Liu, Q., & Liu, G. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2568972 · Cited by 1
Mosele, F. C., Gabriel, A. G., dos Santos, N. J., Barquilha, C. N., Monção, C. C. D., de Lima, M. C., Rubin, M. A., Felisbino, S. L., & Triscott, J. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.124175 · Cited by 2
Potential Role of Adiponectin Receptor Agonist, AdipoRon in Cardiometabolic Disease
Cho, E., & Lee, S. (2019) · Exercise Science · doi:10.15857/ksep.2019.28.2.102 · Cited by 1
Yoshida, K., Nakae, H., Satoh, K., Suzuki, Y., Hirasawa, N., Kameyama, K., & Okuyama, M. (2024) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.14216 · Cited by 1
Acid sphingomyelinase downregulation alleviates diabetic myocardial fibrosis in mice
Chen, C., Ji, Y., Liu, H., Pang, L., Chen, J., Chen, H., Yao, Y., Ye, J., Wang, S., Liu, S., et al. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05206-1 · Cited by 1
Potential targets of protecting podocyte in glomerular aging and injury
Zhong, Z. (2025) · Discover Medicine · doi:10.1007/s44337-025-00384-9 · Cited by 1
Isolating and Culturing Mouse Podocyte Cells to Study Diabetic Nephropathy
Vasilopoulou, E. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9841-8_5 · Cited by 1
Ganesh, V. (2022) · Bioinformation · doi:10.6026/97320630018876 · Cited by 1
Antidiabetic features of AdipoAI, a novel AdipoR agonist.Preprint
Tu, Q., Ahuja, A., Zboinski, E., das, S., Zhu, Z. X., Ma, Q., Xie, Y., & Chen, J. (2023) · doi:10.22541/au.168863049.91214545/v1 · Cited by 1
Liu, T., Xia, M., Zhang, Y., Wang, Y., & Zhou, Y. (2021) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh200519031l
Zhang, J., Li, Y., Liu, J., Han, F., Shi, J., Wu, G., Wang, K., Shen, K., Zhao, M., Gao, X., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4077250
AdipoRon engages microglia to analgesia through the AdipoR1-AMPK pathway in SNI micePreprint
Fang, Q., Wang, Y., Liu, X., Shi, Y., Chen, J., Zhan, H., Zeng, Y., & Wu, W. (2022) · Research Square · doi:10.21203/rs.3.rs-1683288/v1
Metadata
- Authors
- Kim, Y., Lim, J. H., Kim, M. Y., Kim, E. N., Yoon, H. E., Shin, S. J., Choi, B. S., Kim, Y.-S., Chang, Y. S., & Park, C. W.
- Affiliations
- The Catholic University of Korea Incheon St. Mary's Hospital (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- The Catholic University of Korea Yeouido St. Mary's Hospital (KR)
- Corresponding author
- Park, Cheol Whee
- Venue
- Journal of the American Society of Nephrology
- Published
- 2018-01-12
- Volume
- 29
- Issue
- 4
- Pages
- 1108-1127
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- PMC
- PMC5875945
- OpenAlex
- W2783996679
- Cited by
- 229
- References
- 40
- Citations by year
- 2026: 19 · 2025: 31 · 2024: 41 · 2023: 28 · 2022: 30 · 2021: 23 · 2020: 28 · 2019: 22 · 2018: 7
- FWCI
- 16.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Yonsei University
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- AdipoRon, adiponectin receptor agonist, diabetic nephropathy, type 2 diabetes, AMPK, PPARα, CaMKKβ, LKB1, AdipoR1, AdipoR2, glomerular endothelial cells, podocytes, oxidative stress, apoptosis, endothelial dysfunction, intracellular calcium, cardioprotection, db/db mice
- MeSH terms
- Animals, Cells, Cultured, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Glucose, Humans, Male, Mice, Inbred C57BL, Mice, Obese, Phosphorylation, Piperidines, Protein Processing, Post-Translational, Apoptosis, Protein Serine-Threonine Kinases, Oxidative Stress, Endothelial Cells, PPAR alpha, Podocytes, Mice, Adiponectin, Receptors, Leptin, Receptors, Adiponectin, Calcium-Calmodulin-Dependent Protein Kinase Kinase, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review